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Astract -This work addresses the rising need for a diagnostic tool 
for the evaluation of the effectiveness of a drug treatment in 
Parkinson disease, allowing the physician to monitor of the patient 
gait at home and to shape the treatment on the individual 
peculiarity. In aim, we present a cyber-physical system for real­
time processing EEG and EMG signals. The wearable and wireless 
system extracts the following indexes: (i) typical activation and 
deactivation timing of single muscles and the duty cycle in a single 
step (ii) typical and maximum co-contractions, as well as number 
of co-contraction/so The indexes are validated by using Movement 
Related Potentials (MRPs). The signal processing stage is 
implemented on Altera Cyclone V FPGA. 
In the paper, we show in vivo measurements by comparing 
responses before and after the drug (Levodopa) treatment. The 
system quantifies the effect of the Levodopa treatment detecting: 
(i) a 17% reduction in typical agonist-antagonist co-contractions 
time (ii) 23.6% decrease in the maximum co-contraction time (iii) 
33% decrease in number of critical co-contraction. Brain 
implications shows a mean reduction of 5% on the evaluated 
potentials. 
Keywords-EEG, EMG, MRPs, Gait, FPGA, Parkinson desease, 
Levodopa administration 
I. INTRODUCTION 
Parkinson's disease (PD) is a long-term degenerative disorder 
of the central nervous system, resulting in motor impairment. 
Typically, the cardinal features of PD are resting tremor, 
rigidity, bradykinesia and gait disturbance followed by 
disequilibrium [1]. Nowadays, PD affects 1% of the over 60 
year-old population and the 4% of those over 80: globally, 
about 7 million people [2]. In Parkinson's disease, certain nerve 
cells (neurons) in the brain gradually break down or die. Many 
of the symptoms are due to a loss of neurons that produce a 
chemical messenger in the brain called dopamine. When 
dopamine levels decrease, it causes abnormal brain activity, 
leading to signs of Parkinson's disease. 
[n order to make personalized medicine be successful, the major 
challenges to address are the development of accurate 
diagnostic tests that detect a pathology in its early stage and 
identify patients who can benefit from targeted therapies. 
Emerging new tools in PD analysis such as molecu[ar imaging 
(PET/SPECT imaging) [4] and OM[CS [5] have made it 
possible to customize the health care of individual PD patients, 
basing on a physiological and pathological knowledge of the 
subtype and the stage of the disease [3]. The Deep Brain 
Stimulation (DBS) is a promising surgical procedure for the 
treatment of advanced PD. The mechanism of DBS [6] is 
blocking abnormal neural signals, which lead to clinical 
symptoms of PD sending electrical impulses to specific brain 
 
regions. From the perspective of precision medicine, one of the 
key considerations in DBS is selecting the most effective target 
area individually for the specific patient. These types of 
prognostic approaches are highly accurate, but they still do not 
allow a real-time evaluation of the impact. Furthermore, DBS 
is an invasive technique suggested only in advanced PD patients 
due to the high cost of the operation and because of the need of 
change the implanted device every 10 years. 
Instead, on the drug side, no significant progress has been 
achieved: the Levodopa, releasing dopamina, has remained the 
most effective treatment since [960. Nevertheless, the scientific 
community has demonstrated a very high variability of the 
efficacy of a single treatment from one subject to the other [3]. 
Some patients also develop severe side effects that make, de 
facto, their situation even worse. 
In the meantime, wearable sensor technology offers an 
encouraging solution to the above-mentioned challenge since it 
performs high degree of objectivity, sensitivity, good accuracy 
and real-time operability, allowing the monitoring during the 
everyday life with a discrete comfort degree. Interesting 
wearable solutions have been proposed in literature aiming help 
patients with therapeutic administration, by using automatic 
assessment of gait analysis indexes. eGa[T system [7] and 
Parkinson's Kinetigraph based (PKG) system [8] are some 
examples. Both evaluate only accelerometer and gyroscope 
responses, neglecting cortical and muscular implications, but 
translating a typical visual inspection in an unambiguous signal. 
Furthermore, classifications algorithms and evaluations are 
entrusted to computing units (i.e. PC) in post-processing 
(offline) mode. eGaIT [7] does not provide useful information 
about PD's cardinal features (i.e. dyskinesia). Finally, PKG [8] 
excludes from the assessment the postural instability. 
[n this frame, we propose a gait cortico-muscular indexes 
evaluation platform for PD patients. The architecture - fully 
implemented on Altera Cyclone V FPGA - combines and 
processes in parallel both electroencephalographic (EEG) and 
electromyographic (EMG) bio-signals in order to define in real­
time the modulation of ad hoc calculated indexes to characterize 
the gait. For instance, the monitoring of these quantitative 
parameters before and after a treatment allows verifying the 
degree of effectiveness of the treatment, which is dispensed to 
the patient. The here proposed Cyber-Physical System (CPS) is 
an improved version of the system implemented in [9]. 
Differently from [9], this CPS implements a novel stage for 
muscular indexes evaluation, allowing precise gait analysis. The 
platform has been tested on a Parkinson's diseased (PD) patient 
before and after the Levodopa treatment. 
This paper presents detailed results of the above-mentioned in 
vivo measurements, highlighting quantitative gait modification 
due to the effect of Levodopa. The structure of the paper is 
outlined in the following. Section II introduces the basic 
medical knowledge for gait analysis, focusing on both EEG and 
EMG evaluation. Section III outlines the CPS architecture and 
previous implemented EEG-EMG branches. Section IV 
introduces the new computing block for the patient muscular 
status evaluation and its implementation on FPGA. Section V 
presents experimental results. Section VI concludes the paper. 
II. THE ARCHITECTURE BACKGROUND: PREVIOUS WORK 
Exploiting the Cyber-Physical System (CPS) proposed in our 
previous works [9, 12-14], a new computing branch has been 
added to the overall architecture, aiming to extrapolate useful 
indexes related to abnormality in walking pattern, which are 
typical features of neurological patients as the ones with PD. 
Recognizing and quanti tying the typical drift in gait alterations 
indexes (brain or muscular implications) allows to outline the 
positive/negative effects of a specific drug treatment, and thus 
makes possible to adjust the dose if needed. 
The CPS consists of a wireless body area network (WBAN) 
linked to a gateway, which collects and on-line processes the 
EEGs and EMGs signals. The CPS calculates muscular 
activation and cortical implication flags, for the recognition of 
voluntary movements. 
Medical Background 
Before performing a voluntary movement, our brain activates a 
cerebral process dedicated to the ideation and activation of a 
proper muscles sequence stimulation. This brain process starts 
1 second before the muscle activation. The occurrence of the 
EEG Movement Related Potentials (MRPs), before the EMG 
activation, shows the movement intentionality, as well as its 
magnitude returns an objective evaluation of the cerebral cortex 
implication in the specific movement. [10]. As in [9], the 
implemented CPS focuses on three MRPs: 
Bereitschaftspotential (BP), Il and � rhythms. BP ranges in 2-5 
Hz band reaching its magnitude peak about 200ms before the 
movement onset [10]. The Il-rhythm occupies the 7.5-12.5 Hz 
band (and primarily 9-11 Hz), and can be defined as a kind of 
steady state of motion. Il -rhythm is suppressed after the motor 
action [10]. The �-rhythm ranges between 12.5 and 30 Hz. �­
waves recorded in the motor cortex are associated with the 
muscle contractions that happen in isotonic movements. [10]. 
MRPs are more visible on the motor cortex. In parallel, EMG 
are processed in order to both evaluate the cortical implication 
during the movement (extracting a Trigger signal), and to 
extrapolate muscular parameters (analyzing the Trigger Signal). 
The synergic assessment of EMG and EEG parameters provides 
an objective version of the Unified Parkinson's Disease Rating 
Scale (UPDRS) - III and IV part Score in Gait Evaluation [II], 
which is a clinical rating scale composed by discrete grading 
scores from 0 to 4 that allow the evaluation of the motor 
symptoms in PD. The Section III concerns a general Motor Test, 
assessing the motor cardinal features of PO subject. The Section 
IV deals of long-term Motor Complications - nonobjective -
inspection (i.e. the assessment of the drug effects during long 
Fig. l. Architecture of the proposed system. EEG and EMG signals are 
wirelessly collected by a central unit which includes an implementation of the 
proposed architecture, here validated on an FPGA. 
period is left to caregivers, which must return a precompiled 
module with personal evaluation of the patient health status). 
These score are often left to the physicians' expertise. 
Aiming to uniform the physicians' evaluation, the extracted 
indexes are: agonist-antagonist muscles co-contractions, co­
contractions Haste Rate (HR), i.e. the number of co­
contractions/s, activation and relaxation times for of each single 
muscle under investigation. The first two muscular indexes, 
jointly with the MRPs presence/absence, allow compiling the 
UPDRS-III section related to postural stability and involuntary 
movement. These indexes (co-contractions, HR, and MRPs) 
provide significant information about the unbalance, instability 
and involuntary muscles cross-activation (dyskinesia). The 
single muscle parameters (activation and relaxation times) 
contribute to fill of the UPDRS scale in Section III and IV. They 
allow the evaluation of the bradykinesia degree (i.e. slowness 
or abnormal muscular hyperactivity). In addition, they allow to 
objectively assessing motor fluctuations in long period, which 
are linked to a wrong dose of drug, by using a set of muscle 
activation/relax timer (known in Section IV [11] as State ON­
OFF). 
III. THE CYBER PHYSICAL SYSTEM 
Hardware. The system, outlined in Fig.l, uses 8 EMG 
electrodes and 8 EEG ones. The EMG electrodes are placed on 
Gastrocnemius, Tibialis, Rectus and Biceps Femoralis of both 
the legs. The EEG electrodes, according to the international 10-
20 system, cover the pre-motor cortex area with T3, T4, C3, C4, 
Cz, P3, P 4 positions. O2 electrode is used for noise reduction. The 
EMG signals are sampled at 500Hz with 16bit resolution while 
EEG channels have the same sampling rate (500Hz) and 24bit 
resolution [12-14]. A wireless and wearable recording system 
collects both the signals and sends them to a gateway. The signal 
processing is performed in real-time on an FPGA. 
Working Principle. The EMG electrode detects the movement, 
due to a muscle contraction (Trigger), and magnitude level 
overcomes a learned baseline (Edge Enable). The trigger 
enables the computing unit that operates a time-frequency 
analysis on the EEG data, in the 500ms preceding the 
movement. The EEG analysis consists of a MRPs detection by 
using thresholds based approach. The overlap of the dynamic 
thresholds detects three MRPs flags for each channel - 21 flags 
in total, identifying the voluntariness of the movement (see Fig. 
1). Here we introduce in the FPGA, a novel computation block 
with respect to [9, 12-14], the Muscular Index (MI) block, which 
follows the Trigger generator one (in orange in Fig. 1). It extracts 
in real time 36 MIs from EMG signals, supporting the cortical 
implication information. 
Algorithm. The movement detection is entrusted to I-bit 
trigger signals (one trigger for each muscle) obtained by 
dynamic-threshold approach [12]. The EMG is stored in an M 
samples shift-register (M = 512 -I s). The mean value of all 
register samples defines the global average (GA) and it is used 
as threshold. A second average is computed on the last N 
samples (with N<M). For this local averages (LA), our design 
adoptsN= 128 samples (�250ms). Finally, the LA is compared 
with the GA threshold. Since the threshold is dynamically 
updated (as soon as an EMG sample arrives), the algorithm 
allows to follow the trend of the muscular tone continuing to 
work properly. The EMG trigger stays at high level until the 
local power is larger than the dynamic threshold. The EEG 
branch works in parallel with the EMG one. Once a new EEG 
sample arrives, data are stored in a 256 samples shift register and 
when a rising edge on the coupled EMG is detected, a 256 points 
24bit resolution Fast Fourier Transform (FFT) is computed on 
the previous 256 EEG (�500ms before the movement). The 
obtained power levels for each EEG channels are then compared 
to fixed thresholds in order to evaluate the voluntariness of the 
EMG contraction. EEG thresholds are subjectively calibrated 
during a Machine Learning stage [12]. With its high parallelism, 
between EMG and EEG data, the previous CPS [9] was able to 
recognize critical situations during gait and to quickly provide 
(less than 300ms) a postural corrective action. 
A. Previous FPGA Implementation: EEG-EMG Branches 
The global system clock is set to 8.19209MHz (signal 8 MHz 
eLK), obtained with an on-chip Phase-Locked Loop (PLL) 
from the embedded 50MHz oscillator. The global signals of the 
whole implementation are: Reset, an asynchronous reset, 
Enable, an enable signal which freezes the processing; 500Hz 
CLK, an input data clock signal from the EMG and EEG 
channels (500Hz frequency). 8 EMG and 7 EEG branches works 
in parallel on FPGA [9]. The following section briefly 
summarizes the FPGA implementation of the CPS [9] in order 
to help the understanding the operation of the Mis block. 
EEG Computing Branch. Within the branch there is a 256 
point 24 bit resolution FFT processor based on a butterfly 
structure. The 256 EEG samples to be transformed are 
dynamically stored in a 256 24bit words RAM addressed by a 
loop address counter. When EMG Trigger rises to '1', the 
256 samples stored into the RAM are passed the FFT block by 
properly temporizing through a series of dedicated states. A 
MRP Calculator interprets the FFT output data in order to 
extract the BP, Il and � powers, in natural units (BP, MU, BETA 
signals). Finally, BP, Il and � are compared to fixed thresholds 
related to the subject, preloaded on the FPGA [9]. 
EMG Computing Branch. As shown in Fig. 2, the EMG 
samples are squared and passed to two blocks named GA and 
LA FSM. The FSMs calculate the dynamic threshold (G _ Pwr) 
and the local power (L Pwr). 
Fig. 2. Schematic diagram of a single EMG branch 
Basing on two block RAM (GA and LA in Fig. 2), when a new 
EMG data is sampled and stored (New_Data goes' I '), the last 
sample, previously inserted, is pointed and "pop" (5 12th and 
128th for GA and LA RAM, respectively) in a FIFO-like 
functionality. The read sample is subtracted and the new sample 
is added to refresh the overall power, Sum, within the window. 
The FSMs overwrite the RAM word with the new data. The 
128bit based FSM differs from the 512bit based one, because 
in the LA Sum is divided by 128 (it is traduced in a 7bit right 
shift) while for the GA by 512 (9bit right shift). A 64bit 
comparator ( » compares the powers calculated by the two 
blocks (G_Pwr and L_Pwr). L_Pwr is also compared to the 
learned fixed threshold that prevents uncontrolled activation 
connected to noisy events (BL). The comparator provides a 1 bit 
EMG Trigger, used both in the EEG and muscular 
computing. 
IV. ARCHITECTURE IMPROVEMENT: THE MUSCULAR INDEXES 
The precision medicine has led to the demand for more 
objective and on-line assessments of the patient's muscular 
status. The objective knowledge and quantification of these 
parameters help identify the stage of the disease and allows to 
shape a particular treatment accordingly, on the basis of the 
specific needs. In order to provide quantitative parameters for 
the complete gait analysis and aiming to assess benefits and side 
effects of particular treatments (in our application: Levodopa 
administration), without post processing needs, an improvement 
on the system was needed. 
Referring to the Fig. 1, the MIs branch concludes the EMG 
block operating after trigger generation through a set of time 
counter driven by the system clock. In particular, the system 
generates a first set of 1 bit co-contraction signals. A co­
contraction signal is obtained by the overlap of two muscle 
triggers that operate as agonist-antagonist couple (i.e. Left 
Rectus and Biceps Femoralis). On 8 coupled EMG, 4 co­
contractions signals are extracted. The Mis block computes the 
co-contraction time (number of sample between positive and 
negative edge of the signal) providing a quantitative value with 
2ms resolution time. 
The system extracts the HR, counting the co-contractions' 
peaks during a second of acquisition (512 samples). 
Furthermore, the system derives three single muscle 
contraction time, relaxation time and the step duty cycle. 
Specifically, the step duty cycle is defined as: 
DC(%) = tcon • 100 
tcon+trel 
(I) 
where tcon and trel are contraction and relaxation times on each 
muscle, respectively. tcon + trel corresponds to the step time. 
Signal processing outcomes are stored (for post-processing 
operations necessity) and real-time displayed to the user (i.e. 
physician in outpatient applications or caregivers). 
A. General features of FPGA Implementation 
The architecture has been implemented on FPGA (Altera 
Cyclone V 5CSEMA5F31C6N) with the future goal of an ASIC 
implementation [15 - 19]. In our design, 16 bio-signals (8 EEG 
and 8 EMG channels) inputs and 57 outputs, have been used. 
The inputs, coming from signal conditioning circuits [17], are 
serially canalized on 16 FPGA GPIO ports. Finally, they are 
subjected to filtering and decimation. The 57 outputs, which are 
functionally distributed on the remaining available GPIO ports, 
consist of: 
• 7 (motor- cortex channel) BP, fl and � 1 bit flags (21 
parameters), already present in [7]; 
• 4 co-contraction 1 bit signals, already present in [7] . 
• 4 co-contraction time values of 11 bit (2ms time resolution 
on a full scale of about 2s). 
• 8 contraction and 8 relaxation times of 11 bit. 
• 8 duty cycles with 7 bit (1 % resolution). 
The need for an immediate response, has led to the development 
of an interface that allows both the post-processing of the 
acquired data and the on-line evaluation of the MRPs and M[s 
(i.e. through a set of displays). 
B. The MIs Computing Branch on FPGA 
Fig. 3 schematically explain the operation process of a single 
M[s computing branch. Eight M[s branches are present in the 
architecture, one for each monitored muscle. [t operates serially 
with the Trigger signal, and thus, when the Trigger goes 
'1' the Contraction Counter starts increasing its value 
by 1 bit, every time a 500Hz CLK positive edge occurs. 
A similar operation is carried out on Re 1 axa t i on Coun t e r 
that is fed by the Tr igger'. Since a clock of 500 Hz allows 
a resolution of 2ms, the counters are in "module 2" mode 
(outcomes are multiplied with decimal 2). When the step is 
ended, both the counter are ready for the output. Indeed, the 
loop counter does not reset the Contra Time because the 
Trigger signal work as count enable, allowing it to be 
available in parallel with Relax Time. A progressive bit sum 
realizes the Step Time. When the second Trigger positive 
edge arrives (that corresponds to the step time) all the MIs 
extracted until now are stored and then "popped out" by a 2 
pulses based P[PO register, under the piloting of the I bit Reg 
EN. A delayed version (two 8MHz Clk pulses) of Reg EN 
resets Contraction and Relaxation Counters, in 
order to allow the data transfer before the asynchronous reset. 
In this way, all the useful values (Contra Time, Step 
Time) are simultaneously present downstream from the P[PO 
for the entire next step time. 
Fig. 3. Schematic diagram of a single MIs branch 
This approach isolates the counting section, generating a static 
calculation section for the DC. 
Here, the high level time (Contra Time) is first multiplied 
for 100 (decimal) and then divided by the entire step duration 
(Step Time). The quotient in output represents the integer 
value of the DC (7bit). The remain of the divider block is 
defined as a binary subtraction between Step Time and 
Contra Time. It is multiplied with 100 (decimal) and thus 
divided for the Step Time. [f the quotient overcomes 50 
(decimal) the DC is increased by one. This process halves the 
error. Agonist and Antagonist muscle triggers jointly 
contribute, through an AND gate, to generate the square co-
contraction waveform. Similarly to 
Contraction/Relaxation Counters, the co-
contractions time is evaluated (Co Con Time) and returns its 
value when the step - in which the co-contraction is contained -
end. 
e. Data Compressing and Output Management on FPGA 
Since the overall number of extracted parameters (57) with an 
output data rate of 2157bps (256bit on 120ms for Single Muscle 
Paramo and 24bps for co-contraction quantification) overcomes 
the outputs available by the FPGA (24 ports), it has been 
necessary to compact output data that operates in parallel 
(Contra Time, Relax Time and DC). The system 
generates a 32 bit word for each channel, putting in append the 
values as shown in Fig. 4 under the term "Data Compressing". 
Analyzing the gait biomechanics through a post processing of 
all triggers, it arose a timing issue to send the data in output, 
due to the contemporary behavior of certain muscles (i.e. 
Biceps Fern. and Tibialis in terminal swing phase of the gait). 
[n order to avoid the congestion on the outgoing data, the output 
system needs to be synchronized with the biomechanics timing. 
The system divides the temporization branches into Upper 
Section for Rectus and Biceps Femoralis and Lower Section for 
Gastrocnemius and Tibialis. Fig. 4 shows, starting from the top, 
the sequential muscles alternation for the lower section: Right 
Gastrocnemius, Left Tibialis, Right Tibialis and Left 
Gastrocnem ius. 
In order to minimize the needed RAM blocks and outputs, a 
synchronized R&W section has been realized. Fig. 4 
summarizes the operation referring only to lower section of the 
legs, The system exploits the Reg EN I signals coming from 
each channel (used for the parallel output process, and thus, 
named Reg EN PO) in order to generate a square waveform, 
which increase a loop address counter (2 bit). It pilots both the 
4x1 multiplexer block and the RAM address. A delayed version 
of the signal downstream the OR gate works as Wri te 
Enable (avoiding operation on RAM during addressing 
edge), and a shifted version of the signal is used as clock for the 
read operation (dotted temporal diagram). 
A similar system is used for the upper section, which is based 
on the biomechanical order: Right Rectus, Left Biceps, Left 
Rectus, and Right Biceps. 
V. RESULTS 
In this paper, we present a dataset including EEGIEMG and MIs 
obtained by a subject affected by Parkinson disease (PO), 
performing natural gait. The subject is asked to perform a 
natural and fluid walk in a straight path of 10m for 10 times (5 
before and 5 after treatment) within a time range of 120 min, 
starting from the Levodopa administration. The duration of 
each gait was about 50 s, interspersed by 10 min. These clinical 
tests are performed in a controlled environment (local hospital), 
under the supervision of specialized staff. The assessment 
regards the short-time impacts of the Levodopa on the patient. 
The present section provides quantifications of the considered 
diagnostic indexes. We expect to find only the benefits, linked 
to the drug, by an assessment in the short time. 
A. Cyber-Physiscal System Performance 
The overall FPGA implementation uses 28967.5/32070 
(90.3%) ALMs, 50177 ALUTs, 48020/64140 (74.9%) 
registers, 10.3% block memory of the available resources. 
Table I defines the resource utilization of the architecture. The 
first entity in the Table I summaries the resources consumption 
of 8 EMG triggers and 4 Co-contraction signal generation. The 
second row quantify the MRPs calculation resources needs for 
7 EEG. The third entity (Single Muscle Parameters) concerns 
the utilization concerns the extraction of Contra Time, 
Relax Time and DC for 8 EMG channels. The fourth 
subsystem is related to the extrapolation of CoCont Time 
and HR for 4 agonist-antagonist couples. The voice Single 
Muscle Out Management refers to the output data canalization 
in a single output pin with biomechanics timing, for lower and 
upper section (Section IV.C). The only MIs system uses 2784 
logic elements out of 32070 available, 256/4065280 memory 
elements RAM and registers 944/64140. 
T ABLE I FPGA RESOURCES UnLTZA nON 
ALMs REGISTERS MEMORY BLOCK SIJB-SVSTEM (TOT: 32070) ALliTs (TOT: 64140) (BITS) (TOT : 4065280) 
COMPLETE SYSTEM RESOURCES CONSUMPTION: RESOURCES BY ENTITY 
EMG Triggers 1836.2 (5.7%) 3880 1432 (2.2%) 163840 (4.0%) Generation 
MRPs Calculator 23996 (74.8%) 40286 45227 (70.5%) 255164 (6.3%) 
Single Muscle 2657.6 (8.3%) 5264 800 (1.3%) 0 Parameters 
Coupled Muscles 44 (0.14%) 48 120 (0.2%) 0 Parameters 
Single Muscle Gut 73 (0.23%) 38 24 (0.04%) 256 (0.006%) Management 
Total 28967.7 (90.3'%) 50177 48020 174.9'%) 419260 (10.3'%) 
B. Experimental Results in Gait Analysis 
The parameters here reported and discussed are obtained 
considering the average on first 5 walks as "Before drug 
treatment" status (blue background in Table II), and the 5 final 
walks as "After drug treatment" status (red background in Table 
II). The results summarized in Table II quantify the muscular 
implications of the drug treatment in the short time. The Fig. 5 
and Table II show: 
1. The maximum co-contraction time is reduced of23. 6% after 
the treatment. Before the Levodopa administration PO 
subject had a maximum co-contraction of 840ms; after the 
application the maximum reaches 628ms on R. Rect-R. Bic. 
2. The HR is, on average, reduced of 23.3% after the treatment. 
PO subject exhibits 1.92 co-contractions/s and 1.02 co­
contractionsls respectively before and after the treatment. 
Co-contractions are less frequent in PD after the Levodopa. 
Dangerous co-contraction decrease is also highlighted in 
Fig. 5 with a red circle. 
3. The co-contractions show a decrease of 53ms (average 
value on all the four muscles couples), here with greater 
incidence on the right leg (i1t=-51ms on R.Gast-R. Tib and 
i1t=-78ms on R. Bic - R. Rect). 
4. On single muscle, the duty cycles follow an opposite trend, 
showing an average increase of 2.25%. It represents an 
increase o{the muscular activity during the step (i.e. due to 
the stretching in time of the contraction) 
5. The contraction time on single muscle is reduced, on 
average, of 5.4% (576ms--->544ms), similarly the relaxation 
is reduced of 18.8% (546ms--->443ms). This behavior is 
linked to the loss of the slowness status. Indeed, step time 
after Levodopa is reduced of lOOms, startingfrom 1.2s. 
During the gait, significant differences on MRPs were found, 
showing a reduction of intentionality in the phase of motor 
TABLE II. MIs EXTRACTED BY THE CPS 
L RECT I L BICEP RTIB IRGAST LTIB ILGAST R RECT R BICEP 
Coco Max 496 566 464 840 
(ms) 418 396 516 628 
Coco Typ 312±88 22l±90 176±72 334±l86 
(ms) 282.5±90 170±60 272±150 256±l50 
HR 1.04 25/24) 1,25 (30/24) 1,58 (38/24) 1,92 (46/24) 
(Cocontr.!s) 1.04(52/50) 1.04(52/50) 1.1 (55/50) 1.02 51/50) 
Contra time 440±130 680±110 616±300 518±172 606±190 502±270 478±232 770±282 
(ms) 444±108 568±130 613±228 470±272 650±130 552±250 446±200 614±130 
Relax time 558±204 708±422 570±94 494±216 716±390 512±206 588±70 222±120 
(ms) 642±136 372±222 296±122 466±108 404±144 416±300 540±88 414±266 
44 49 52 50 46 50 55 78 
DC('Yo) 41 60 67 50 62 57 45 60 
Fig. 4. Schematic diagram for data compressing and output management  
Fig. 5. The co-contraction versus BPs during a gait 
TABLE III. MRPs EXTRACTED BY THE CPS 
T3 P3 C3 CZ C4 P4 T 
67.8±8.S 63.8±6.7 62.3±6.7 6S.6±!3 6S.!±7.4 63.8±!3 66.2±!2 
BP(dB,,) 
60.7±6.3 62.3±S.6 62.7±S.4 62.4±S.! 60.9±S.9 62.4±S.2 62.9±S.7 
rrJ 
� 49.2±2.3 SO.1±2.9 49.0±2.4 47.9±9.1 47 0±9.0 52.3±9.5 49.0±9.0 " (dB,,) 
::;s 48.S±2.3 48.9±2.9 48.6±2.7 48.3±2.7 46.6±3.0 49.6±2.7 48.3±3.0 
40.!±3.3 41.0±2.8 39.6±2.3 39.6±7.S 40.!±7.2 4S.0±4.3 40.8±2.8 
P (dB,,) 
39.31±2 8.9±2.7 37.8±3.2 36.6±3.3 36.1±3.3 41.4±2.2 37.4±3.2 
ideation, typical of recurring movements. The decrease is also 
linked to the parallel decrease of dangerous co-contractions. 
Table III and Fig. 6 show the Levodopa brain modulation in 
terms of BP fl and � rhythm mean and standard deviation of 
normalized PDFs. The BP before the Levodopa treatment (blue 
gaussian) has a mean of 64.9 dBfl (average on all the 7 motor­
cortex channels) and standard deviation of 9.61 dBfl. After the 
Levodopa the BP reaches a mean of 62.1 dBfl and a standard 
deviation of 5.6 dBfl. A relative reduction of 4.3% (2.8dBfl) in 
BP is recorded. Similarly, the fl- rhythm shows an absolute 
reduction ofO.8dBfl, or relative one of l.6% (49.2dBfl±6.3dBfl 
---+ 48.4dBfl±6.3dBfl). �-rhythm moves from 40.9dBfl±4.3dBfl 
to 38.2dBfl±2.8dBfl with a relative decrease of the 6% 
(2.7dBfl)· 
VI. CONCLUSION 
In this work, a cyber-physical system for gait indexes extraction 
and computing have been implemented and tested for the 
evaluation of the short-time effects of the Levodopa 
administration. The system is made up by 8 EEG and 8 EMG 
wireless nodes for real-time synchronous data collection. The 
system calculates 57 different indexes, estimating the corti co­
muscular implications during a movement. An FPGA (Altera 
Cyclone V) implementation, including test and validation of the 
system has been presented, with a future goal of a more efficient 
output data management in a long time acquisition (big data 
issue in indexes storage - 2157bps). The system has been tested 
on a subject affected by PD, before and after taking Levodopa, 
performing a standard clinical gait protocol. The experimental 
outcomes show a situation of benefits linked to the Levodopa 
such as a reduction in critical muscular behaviors and a 
modulation of the brain motor ideation, respecting expectations 
of the drug. The system is therefore highly sensitive to 
situations such as motor fluctuations associated with bad drug 
dosages. According to the dictates of precision medicine, this 
feature makes it a useful tool for treatments evaluation. 
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